Mind Body Program for Fear of Recurrence
赞助:
Beth Israel Deaconess Medical Center
合作者:
信息的提供 (责任方):
Gloria Y. Yeh,Beth Israel Deaconess Medical Center
追踪信息 | |||
---|---|---|---|
首次提交日期 ICMJE | October 2, 2018 | ||
首次发布日期e ICMJE | October 4, 2018 | ||
最后更新发布日期 | October 4, 2018 | ||
预计研究开始日期 ICMJE | August 9, 2017 | ||
预计主要完成日期 | June 30, 2019 (主要结果测量的最终数据收集日期) | ||
目前主要观察指标 ICMJE |
Feasibility[ Time Frame: Through study completion (approximately 5 months) ] The primary metric for assessing Feasibility will be retention at the initial follow-up assessment. Reasons for ineligibility, refusal, or dropping out will be measured. Acceptability[ Time Frame: During intervention group sessions (approximately 2 months) ] The primary metric for assessing Acceptability will be a five-item, investigator developed self-report questionnaire. Following each study session, participants will be asked to rate (1=not at all to 5=very much) the enjoyableness, convenience, helpfulness, relevancy, odds of future use, and overall satisfaction of the session. |
||
原始主要观察测量 ICMJE | 与当前相同 | ||
目前的二级观察 ICMJE |
|
||
描述性信息 | |||
简略标题 ICMJE | Mind Body Program for Fear of Recurrence | ||
正式标题 ICMJE | Mind Body Program for Fear of Recurrence | ||
简要概况 | This is a pilot feasibility study of a group-based, mind body intervention for managing stress and fear of recurrence and promoting resiliency among adult cancer survivors. |
||
详细说明 | |||
研究类型 ICMJE | Interventional | ||
研究阶段 | N/A | ||
研究设计 ICMJE | 分配: 干预模型: Single Group Assignment 干预模型描述: 盲法: Interventional 盲法描述: 主要目的: Other |
||
适用条件 ICMJE | |||
干预项目 ICMJE |
|
||
研究工具 |
|
||
招募信息 | |||
招募状态 ICMJE | Recruiting | ||
预计入组 ICMJE |
25 | ||
原始预计入组 ICMJE | 与当前相同 | ||
预计研究完成日期 | April 14, 2020 | ||
预计主要完成日期 | June 30, 2019 (主要结果测量的最终数据收集日期) | ||
合格标准 ICMJE | Inclusion Criteria: 1. Patients must have a history of breast, lung, colorectal, hematologic, prostate, melanoma, or gynecological cancer (by medical record and/or self-report) 2. Completion of primary cancer treatment (radiation, surgery, and/or chemotherapy) between 3 to 30 months ago 3. Ages 18 and older (by medical record and/or self-report) Exclusion Criteria: 1. Self-reported inability to speak and write in English 2. Concurrent participation in weekly, group-based psychosocial or mind-body programs 3. Serious mental illness (by medical record and/or self-report) as defined by history of suicidality, psychosis, and/or psychiatric hospitalization in the past year. 4. Inability to travel to necessary study visits 5. No e-mail address to access online assessments | ||
性别 |
|
||
年龄 | 最小年龄:18 Years ,最大年龄:N/A | ||
接受健康的志愿者 | 没有 | ||
可入组国家 ICMJE | United States | ||
管理信息 | 数据检测委员会 | No | |
研究涉及美国FDA监管的产品 |
研究美国FDA监管的药品: No 研究涉及美国FDA监管的设备产品: No |
||
IPD 共享声明 |
|
||
责任方 | Gloria Y. Yeh,Beth Israel Deaconess Medical Center | ||
研究赞助商 ICMJE | Beth Israel Deaconess Medical Center | ||
合作者 ICMJE | |||
研究员 ICMJE |
|
||
PRS 账户 | Beth Israel Deaconess Medical Center | ||
验证日期 | October 2018 | ||
ICMJE 国际医学期刊编辑委员会和 世界卫生组织 ICTRP 要求的元素 |
请使用微信扫码报名